BackHemab Therapeutics Holdings Common Stock Overview

Hemab Therapeutics Holdings Common Stock Minority Interest

Track Hemab Therapeutics Holdings Common Stock's minority interest ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer trimmed avg / median

Loading

Hemab Therapeutics Holdings Common Stock Minority Interest History

Loading

Hemab Therapeutics Holdings Common Stock vs. peers: Minority Interest Comparison

Loading

Hemab Therapeutics Holdings Common Stock Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Hemab Therapeutics Holdings Common Stock (COAG) FAQ

Hemab Therapeutics Holdings Common Stock (COAG) currently reports a minority interest of $0 as of June 2026. Use the charts on this page to explore Hemab Therapeutics Holdings Common Stock's minority interest history and peer comparisons.

Hemab Therapeutics Holdings Common Stock reported $0 in minority interest as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemab Therapeutics Holdings Common Stock, and consider following COAG for alerts when major investors trade the stock.

Hemab Therapeutics Holdings Common Stock is classified in the Healthcare sector. On minority interest, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing COAG with unrelated industries.